Forest Laboratories Stock Price, News & Analysis (NYSE:FRX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Forest Laboratories (NYSE:FRX)

Forest Laboratories logoForest Laboratories, Inc. (Forest), develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company's products include Namenda, a N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate to severe dementia of the Alzheimer's type; Bystolic, a beta-blocker for the treatment of hypertension; Linzess, a guanylate cyclase type-C receptor agonist for the once-daily treatment for men and women suffering from IBS-C or CIC; Tudorza, a long-acting antimuscarinic agent for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and Viibryd, a SSRI and a 5-HT1A receptor partial agonist for the treatment of adults with depressive disorder (MDD). In February 2014, it acquired Aptalis. Effective July 2, 2014 Forest Laboratories Inc, a unit of Actavis PLC, acquired the entire share capital of Furiex Pharmaceuticals Inc.

Receive FRX News and Ratings via Email

Sign-up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryPharmaceuticals
SectorHealthcare
SymbolNYSE:FRX
CUSIP34583810
Phone+1-212-4217850

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Forest Laboratories (NYSE:FRX) Frequently Asked Questions

What is Forest Laboratories' stock symbol?

Forest Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "FRX."

Who are some of Forest Laboratories' key competitors?

How do I buy Forest Laboratories stock?

Shares of Forest Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Forest Laboratories?

Forest Laboratories' mailing address is 909 3rd Ave, NEW YORK, NY 10022-4731, United States. The healthcare company can be reached via phone at +1-212-4217850.


MarketBeat Community Rating for Forest Laboratories (FRX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  242 (Vote Underperform)
Total Votes:  425
MarketBeat's community ratings are surveys of what our community members think about Forest Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Forest Laboratories (NYSE:FRX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Forest Laboratories (NYSE:FRX) Earnings History and Estimates Chart

Earnings by Quarter for Forest Laboratories (NYSE:FRX)

Forest Laboratories (NYSE FRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/29/2014Q414$0.45$0.87$959.00 million$1.05 millionViewN/AView Earnings Details
1/21/2014Q314$0.06$0.27$827.25 million$846.80 millionViewN/AView Earnings Details
7/23/2013Q1 2014$0.09$0.28$798.41 million$796.90 millionViewN/AView Earnings Details
4/23/2013Q4 2013$0.16$0.17$807.00 million$783.20 millionViewN/AView Earnings Details
1/15/2013Q3 2013($0.14)($0.21)$765.94 million$678.00 millionViewN/AView Earnings Details
10/16/2012$0.02$0.08ViewN/AView Earnings Details
7/17/2012$0.24$0.28ViewN/AView Earnings Details
4/17/2012$0.70$0.78ViewN/AView Earnings Details
1/17/2012$1.01$1.04ViewN/AView Earnings Details
10/18/2011$0.99$0.91ViewN/AView Earnings Details
7/19/2011$0.97$1.04ViewN/AView Earnings Details
4/19/2011$1.07$1.12ViewN/AView Earnings Details
1/18/2011$0.99$1.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Forest Laboratories (NYSE:FRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Forest Laboratories (NYSE:FRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Forest Laboratories (NYSE FRX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Forest Laboratories (NYSE:FRX)

Forest Laboratories (NYSE FRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/27/2014Howard SolomonDirectorSell250,000$65.41$16,352,500.00View SEC Filing  
1/23/2014Howard SolomonDirectorSell250,000$67.13$16,782,500.00View SEC Filing  
1/22/2014Jerome LynchSVPSell135,625$67.28$9,124,850.00View SEC Filing  
8/26/2013Lawrence OlanoffDirectorSell1,104$42.96$47,427.84View SEC Filing  
8/21/2013Perier Francis, Jr.CFOSell12,000$43.00$516,000.00View SEC Filing  
9/4/2012Carl C IcahnMajor ShareholderBuy86,848$34.64$3,008,414.72View SEC Filing  
8/29/2012Carl C IcahnMajor ShareholderBuy331,406$34.65$11,483,217.90View SEC Filing  
8/24/2012Carl C IcahnMajor ShareholderBuy1,343,837$34.57$46,456,445.09View SEC Filing  
8/21/2012Carl C IcahnMajor ShareholderBuy1,962,011$34.18$67,061,535.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Forest Laboratories (NYSE FRX) News Headlines

Source:

SEC Filings

Forest Laboratories (NYSE:FRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Forest Laboratories (NYSE:FRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Forest Laboratories (NYSE FRX) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.